Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec;479(12):3213-3227.
doi: 10.1007/s11010-024-04931-3. Epub 2024 Feb 24.

Neutrophil extracellular traps: a catalyst for atherosclerosis

Affiliations
Review

Neutrophil extracellular traps: a catalyst for atherosclerosis

Yinyu Wang et al. Mol Cell Biochem. 2024 Dec.

Abstract

Neutrophil extracellular traps (NETs) are network-like structures released by activated neutrophils. They consist mainly of double-stranded DNA, histones, and neutrophil granule proteins. Continuous release of NETs in response to external stimuli leads to activation of surrounding platelets and monocytes/macrophages, resulting in damage to endothelial cells (EC) and vascular smooth muscle cells (VSMC). Some clinical trials have demonstrated the association between NETs and the severity and prognosis of atherosclerosis. Furthermore, experimental findings have shed light on the molecular mechanisms by which NETs contribute to atherogenesis. NETs play a significant role in the formation of atherosclerotic plaques. This review focuses on recent advancements in the understanding of the relationship between NETs and atherosclerosis. It explores various aspects, including the formation of NETs in atherosclerosis, clinical trials investigating NET-induced atherosclerosis, the mechanisms by which NETs promote atherogenesis, and the translational implications of NETs. Ultimately, we aim to propose new research directions for the diagnosis and treatment of atherosclerosis.

Keywords: Atherosclerosis; Inflammation; Neutrophil extracellular traps; Neutrophils.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS et al (2019) Atherosclerosis. Nat Rev Dis Primers 5:56. https://doi.org/10.1038/s41572-019-0106-z - DOI - PubMed
    1. Libby P (2021) The changing landscape of atherosclerosis. Nature 592:524–533. https://doi.org/10.1038/s41586-021-03392-8 - DOI - PubMed
    1. Wolf D, Ley K (2019) Immunity and Inflammation in Atherosclerosis. Circ Res 124:315–327. https://doi.org/10.1161/CIRCRESAHA.118.313591 - DOI - PubMed - PMC
    1. Soehnlein O, Libby P (2021) Targeting inflammation in atherosclerosis - from experimental insights to the clinic. Nat Rev Drug Discov 20:589–610. https://doi.org/10.1038/s41573-021-00198-1 - DOI - PubMed - PMC
    1. Adamstein NH, MacFadyen JG, Rose LM, Glynn RJ, Dey AK, Libby P et al (2021) The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials. Eur Heart J 42:896–903. https://doi.org/10.1093/eurheartj/ehaa1034 - DOI - PubMed - PMC

LinkOut - more resources